LONDON, Dec 2 (Reuters) - Britain's medicines regulator did
not cut any corners in the rolling review process that led it to
approve the Pfizer vaccine against COVID-19, the regulator's
chief executive said on Wednesday, describing the review as
thorough and rigorous.
"It's very clear that separate teams have been working in
parallel to deliver the most rigorous review of this vaccine. No
corners have been cut," June Raine said.
"Our expert scientists and clinicians have worked round the
clock, carefully, methodically, poring over tables and analyses
and graphs on every single piece of data, hundreds, over a
thousand pages of data and, absolutely critically, analysing the
pre-clinical evidence, the clinical trials, the manufacturing
and quality controls, and then down to the final sampling."
(Reporting by Guy Faulconbridge and Estelle Shirbon; editing by
William James)
Astrazeneca (AZN)
